- Published at
- by etfdailynews.com
positive
positive
Reviewing Aziyo Biologics (NASDAQ:AZYO) & Brookline Capital Acquisition (NASDAQ:BCAC)
Read Reviewing Aziyo Biologics (NASDAQ:AZYO) & Brookline Capital Acquisition (NASDAQ:BCAC) at ETF Daily News
News for Brookline Capital Acquisition Corp. (BCACU)
- Published at
- by etfdailynews.com
positivepositiveGraham Capital Wealth Management LLC Makes New $110,000 Investment in Brookline Capital Acquisition Corp. (NASDAQ:BCAC)
Read Graham Capital Wealth Management LLC Makes New $110,000 Investment in Brookline Capital Acquisition Corp. (NASDAQ:BCAC) at ETF Daily News- Published at
- by marketwatch.com
mixedmixed- Published at
- by etfdailynews.com
positivepositiveWolverine Asset Management LLC Acquires New Holdings in Brookline Capital Acquisition Corp. (NASDAQ:BCACU)
Read Wolverine Asset Management LLC Acquires New Holdings in Brookline Capital Acquisition Corp. (NASDAQ:BCACU) at ETF Daily News- Published at
- by globenewswire.com
mixedmixedApexigen Completes Business Combination to Become a Publicly Listed Immuno-oncology Company
-Common stock of Apexigen to commence trading on the Nasdaq Capital Market today under the ticker symbol “APGN”- -Clinical pipeline includes multiple...- Published at
- by etfdailynews.com
positivepositiveBellerophon Therapeutics (NASDAQ:BLPH) Now Covered by Analysts at StockNews.com
Read Bellerophon Therapeutics (NASDAQ:BLPH) Now Covered by Analysts at StockNews.com at ETF Daily News- Published at
- by etfdailynews.com
positivepositiveBrookline Capital Acquisition Corp. (NASDAQ:BCAC) Sees Large Growth in Short Interest
Read Brookline Capital Acquisition Corp. (NASDAQ:BCAC) Sees Large Growth in Short Interest at ETF Daily News- Published at
- by etfdailynews.com
positivepositiveFinancial Analysis: Brookline Capital Acquisition (NASDAQ:BCAC) vs. La Jolla Pharmaceutical (NASDAQ:LJPC)
Read Financial Analysis: Brookline Capital Acquisition (NASDAQ:BCAC) vs. La Jolla Pharmaceutical (NASDAQ:LJPC) at ETF Daily News- Published at
- by globenewswire.com
positivepositiveApexigen to Participate in the Brookline Capital Markets Newport Symposium
SAN CARLOS, Calif., July 11, 2022 (GLOBE NEWSWIRE) -- Apexigen, Inc. (“Apexigen”), a clinical-stage company focused on developing innovative...- Published at
- by etfdailynews.com
mixedmixedVerrica Pharmaceuticals Inc. (NASDAQ:VRCA) Insider Christopher G. Hayes Acquires 5,714 Shares
Read Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Insider Christopher G. Hayes Acquires 5,714 Shares at ETF Daily News- Published at
- by globenewswire.com
mixedmixed